Медицинский факультет и год окончания
Медицинский факультет Университета Ege - 2001
Место и год прохождения специализации
Медицинский факультет Университета Ege - 2008 специалист по внутренним болезням
Медицинский факультет Измирского университета Katip Çelebi - 2013 специалист по медицинской онкологии
Медицинский факультет Университета Manisa Celal Bayar - 2015 звание доцента
Медицинский факультет Измирского экономического университета - 2022 звание профессора
Профессиональный опыт
Больница Medicalpark Измир 2021–2023
Центр онкологического консультирования проф. д-ра Ahmet Dirican 2023–2024
Медицинские интересы
Иммунотерапия
Применение «умных» препаратов
Персонализированное лечение
Тесты геномного профилирования при раке
Холистические методы лечения при раке
Все виды лечения рака
Научные публикации
А. Статьи, опубликованные в международных рецензируемых журналах:
A1. Dirican A, Levent F, Alacacioglu A, Kucukzeybek Y, Varol U, Kocabas U, Senöz O, Emren SX, Demir L, Coban E, Aksun S, Sutcu R, Tarhan MO. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and Its Relation to Oxidative Stress. Angiology. 2014 Feb 26. DOI: 10.1177/00033197145231
A2. Dirican A, Kucukzeybek Y, Alacacioglu A, Varol U, Aksun S, Bayoglu IV, Demir L, Coban E, Sutcu R, Tarhan MO. Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. Med Oncol. 2014 Apr;31(4):905. doi: 10.1007/s12032-014-0905-8. Epub 2014 Mar 5.
A3. Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2014 Feb 18. DOI 10.1007/s10147-014-0672-8 [Epub ahead of print]
A4. Dirican A, Kucukzeybek Z, Somali I, Erten C, Demir L, Can A, Payzin B, Bayoglu V, Akyol M, Koseoglu M, Alacacioglu A, Tarhan MO, The association of hematologic parameters on prognosis of patients with metastatic renal cell carcinoma. J BUON. 2013 Apr-Jun;18(2):413-9.
A5. Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V, Akyol M, Ekinci N , Medeni M, Alacacioglu A. One-Day DCF Regimen in Patients with Metastatic Gastric Cancer Tumori. 2013 Mar-Apr;99(2):145-8. doi: 10.1700/1283.14183.
A6.Dirican A, Ekinci N, Avci A, Akyol M, Alacacioglu A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Koyuncu B, Tarhan MO. The Effects of Hematological Parameters and Tumor-Infiltrating Lymphocytes on Prognosis in Patients with Gastric Cancer. Cancer Biomark. 2013;13(1):11-20. doi: 10.3233/CBM-130331.
A7. Dirican A, Kucukzeybek Y, Erten C, Somali I, Demir L, Can A, Payzin KB, Bayoglu IV, Akyol M, Yildiz Y, Koeseoglu M, Alacacioglu A, Tarhan MO. Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Cancer: Second Line Sunitinib Treatment Following IFN-alpha; Preliminary Study. Asian Pacific Journal of Cancer Prevention 2013;14(3):2101-5.
A8. Dirican A, Kucukzeybek Y, Erten C, Somali I, Can A, Bayoglu IV, Akyol M Cardiac rhabdomyosarcoma of the left atrium: a case report. Contemp Oncol (Pozn). 2014;18(1),73-75
A9. Dirican A, Küçükzeybek Y, Somalι I, Erten C, Demir L, Can A, Bayoğlu IV, Ermete M, Altιnboğa AA, Tarhan MO. Cutaneous and subcutaneous metastasis from bladder carcinoma Wspolczesna Onkol 2012; 16 (5): 453–45
A10. Kucukzeybek Y, Dirican A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Medeni M, Tarhan MO. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pac J Cancer Prev. 2012;13(6):2771-4
A11. S Kalemci, N Dirican, E.S Çetin, H Sözen, A.G Üner, A Yaylalı, S Aksun, V Karacam, E Ülger, R Sütcü, A Dirican., "The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice.", European Review for Medical and Pharmacological Sciences. 2013;17(24):3334-40.
A12. Demir L, Akyol M, Bener S, Payzin KB, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Alacacioglu A, Calli AO, Tarhan MO. Prognostic Evaluation of Breast Cancer Patients with Evident Bone Marrow Metastasis. Breast J. 2014 Mar 27. doi: 10.1111/tbj.12264. [Epub ahead of print]
A13. Cokmert S, Demir L, Can A, Akyol M, Vedat Bayoglu I, Dirican A, Kucukzeybek Y, Erten C, Oktay Tarhan M. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. J BUON. 2014 Jan-Mar;19(1):75-82.
A14. Varol U, Oktay E, Yildirim M, Surmeli ZG, Dirican A, Meydan N, Karaca B, Karabulut B, Uslu R. Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer. Mol Clin Oncol. 2014 Jan;2(1):166-170. Epub 2013 Nov 12.
A15. Demir L, Ekinci N, Erten C, Somali I, Can A, Dirican A, Cokmert S, Bayoglu V, Akyol M, Kucukzeybek Y, Alacacioglu A, Tarhan MO. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer. J Surg Oncol. 2014 Jan 24. doi: 10.1002/jso.23563. [Epub ahead of print]
A16. Cokmert S, Demir L, Akder Sari A, Kucukzeybek Y, Can A, Akyol M, Bayoglu IV, Dirican A, Erten C, Tarhan MO. Synchronous appearance of a high-grade neuroendocrine carcinoma of the ampulla vater and sigmoid colon adenocarcinoma.
Case Rep Oncol Med. 2013;2013:930359. doi: 10.1155/2013/930359. Epub 2013 Dec 3.
A17. Can A, Alacacioglu A, Kucukzeybek Y, Erten C, Cokmert S, Demir L, Dirican A, Vedat Bayoglu I, Akyol M, Aslan F, Oktay Tarhan M. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. J BUON. 2013 Oct-Dec;18(4):845-50.
A18. Demir L, Ekinci N, Erten C, Kucukzeybek Y, Alacacioglu A, Somali I, Can A, Dirican A, Bayoglu V, Akyol M, Cakalagaoglu F, Tarhan MO. Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors? Asian Pac J Cancer Prev. 2013;14(8):4751-8.
A19. Erten C, Demir L, Somali I, Alacacioglu A, Kucukzeybek Y, Akyol M, Can A, Dirican A, Bayoglu V, Tarhan MO.Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? Asian Pac J Cancer Prev. 2013;14(6):3711-7.
A20. Demir L, Can A, Oztop R, Dirican A, Bayoglu V, Akyol M, Kucukzeybek Y, Erten C, Somali I, Tarhan MO. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature.J Cancer Res Ther. 2013 Jan-Mar;9(1):125-7. doi: 10.4103/0973-1482.110386. Review.
A21. Tarhan MO, Gonel A, Kucukzeybek Y, Erten C, Cuhadar S, Yigit SC, Atay A, Somali I, Dirican A, Demir L, Koseoglu M. Prognostic Significance of Circulating Tumor Cells and Serum CA15-3 Levels in Metastatic Breast Cancer, Single Center Experience, Preliminary Results. Asian Pac J Cancer Prev. 2013;14(3):1725-9.
A22. Alacacioglu A, Tarhan O, Alacacioglu I, Dirican A, Yilmaz U. Depression and anxiety in cancer patients and their relatives. J BUON. 2013 Jul-Sep;18(3):767-74.
A23. Akyol M, Demir L, Dirican A, Ekinci E, Can A, Bayoglu V, Alacacioglu A, Kucukzeybek Y, Cokmert S, Erten C, Cakalagaoglu F, Tarhan MO. Letter to Editor Skin and maxillary sinus involvement of colon cancer. Contemp Oncol (Pozn). 2014;18(1),70-72.
A24. Demir L, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Altinboga AA, Ermete M, Oztop RM, Tarhan MO. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy Can Urol Assoc J 2012;6(5):E209-E212. doi.org/10.5489/cuaj.11255
A25.Tarhan MO, Demir L, Somali I, Yigit S, Erten C, Alacacioglu A, Ellidokuz H, Seseogullari O, Kucukzeybek Y, Can A, Dirican A, Bayoglu V, Akyol M. The clinicopathological evaluation of the breast cancer patientswith brain metastases: predictors of survival . Clin Exp Metastasis . 2013 Feb;30(2):201-13. doi:10.1007/s10585-012-9528-7. Epub 2012 Aug 23
A26. Yigit S, Demir L, Tarhan MO, Cabuk FK, Ellidokuz H, Erten C, Somali I, Dirican A, Cakalagaoglu F. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma.Neoplasma. 2012;59(5):475-85.
A27. Demir L, Can A, Dirican A, Bayoğlu V, Rezanko TA, Akyol M, Kucukzeybek Y, Erten C, Tarhan MO. Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; review of the literature. Clin Genitourin Cancer. 2012Dec;10(4):280-3. doi: 10.1016/j.clgc.2012.03.003. Epub 2012 Apr 6.
A28. Demir L, Erten C, Yigit SC, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Somali I, Tarhan MO. Intramammary lymph node metastasisin a patient with ovarian carcinoma and a brief review of the literature. współczesna onkologia/contemporary oncology 2012; 16 (2): 108–110
A29. Cuhadar S, Atay A, Koseoglu M, Dirican A, Hur A.Stability studies of common biochemical analytes in serum separator tubes with or without gel barrier subjected to various storage conditions.Biochem Med (Zagreb). 2012;22(2):202-14.
A30.Cuhadar S, Koseoglu M, Atay A, Dirican A.The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med (Zagreb). 2013;23(1):70-7.
A31. Demir L, Somali I, Oktay Tarhan M, Erten C, Ellidokuz H, Can A, Dirican A, Vedat Bayoglu I. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer. J BUON. 2011 Oct-Dec;16(4):682-8.
A32. Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis. 2013 Jul 9. [Epub ahead of print]
A33. Ece H, Cigdem E, Yuksel K, Ahmet D, Hakan E, Oktay TM. The use of oral antidiabetic drugs (metformin and pioglitazone) in diabetic patients with breast cancer: How does It effect on serum HIF-1 alpha and 8OHdG levels ? Asian Pac J Cancer Prev. 2012;13(10):5143-8.
A34. Dirican A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Yigit SC, Unay FC, Yetimalar MH, Tarhan MO. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: Case report. Eur J Gynaecol Oncol. 2012;33(6):652-5.
A35. Dirican A, Atmaca H, Bozkurt E, Erten C, Karaca B, Uslu R. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway. Clin Transl Oncol. 2014 Jul 25. [Epub ahead of print]. DOI 10.1007/s12094-014-1206-6.
A36. Dirican A, Varol U, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Yildiz Y, Koyuncu B, Coban E, Tarhan MO Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab? Asian Pac J Cancer Prev. 2014;15(12):4781-6.
A37. Dirican A, Levent F, Alacacioglu A, Kucukzeybek Y, Varol U, Kocabas U, Senöz O, Emre SV, Demir L, Coban E, Aksun S, Sutcu R, Tarhan MO. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and its Relation to Oxidative Stress. Angiology. 2014 Jun 5. DOI: 10.1177/0003319714536602. [Epub ahead of print]
A38. Varol U, Dirican A, Yildiz I, Oktay E, Degirmenci M, Alacacioglu A, Barutca S, Karabulut B, Uslu R.First-line mono-chemotherapy in frail elderly patients with metastatic colorectal cancer. Asian Pac J Cancer Prev. 2014;15(7):3157-61.
A39. Alacacioglu A, Ulger E, Varol U, Yavuzsen T, Akyol M, Yildiz Y, Yildiz I, Bayoglu V, Dirican A, Demir L, Salman T, Kucukzeybek Y, Alacacioglu I, Can H, Tarhan MO. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Med Oncol. 2014 Jul;31(7):43. doi: 10.1007/s12032-014-0043-3. Epub 2014 Jun 10.
A40. Akyol M, Varol U, Yildiz I, Bayoglu IV, Yildiz Y, Demir L, Dirican A, Can A, Cokmert S, Oztop MT, Alacacioglu A, Kucukzeybek Y, Tarhan MO.Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literature. Case Rep Oncol Med. 2014;2014:826584. doi: 10.1155/2014/826584. Epub 2014 Jun 11.
A41. Kucukzeybek BB, Calli AO, Kucukzeybek Y, Bener S, Dere Y, Dirican A, Payzin KB, Ozdemirkiran F, Tarhan MO. The prognostic significance of bone marrow metastases: Evaluation of 58 cases. Indian J Pathol Microbiol 2014;57:396-9
A42. Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO. Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Asian Pac J Cancer Prev. 2014;15(17):7119-23.
A43. M Akyol, Leyla Demir, A Alacacioglu, H Ellidiokuz, Y Kucukzeybekl, Y Yildiz, V Bayoglu, I Yildiz, T Salman, U Varol, B Kucukzeybek, Lütfiye Demir, A Dirican, R Sutcu, O Tarhan The effects of adjuvant endocrine treatment on the serum leptin, adiponectin and body composition in patients with breast cancer [Izmir Oncology Group (IZOG) Study]. Chemotherapy. 2016; 61 (2): 57-64. doi: 10.1159 / 000440944.
A44. Oktay E, Yalcin GD, Ekmekci S, Kahraman DS, Yalcin A, Degirmenci M, Dirican A, Altin Z, Ozdemir O, Surmeli Z, Diniz G, Ayhan S, Bulut G, Erdogan A, Uslu R. Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors. J BUON. 2019. PMID: 31128036
A45. Dirican A, Sahin O, Taslı F, Sogut E, Kucukzeybek Y, Alacacioglu A, Gunes M, Saglam G, Coban E, Tarhan MO, Demirci B. Thymoquinone enhances cisplatin-induced neprotoxicity in high dose. Journal of Oncological Science. 2016; (1): 17-24
A46. Dirican A, Ekinci F, Erdoğan AE, Öztürk GG. Inflammatory prognostic index score as a new parameter predicting overall survival in renal cell carcinoma. J Surg Med. 2021;5(2):163-167. DOI: 10.28982/josam.850739
A47. Ekinci F, Sarı D, Celik C, Dirican A, Erdogan AP, Goksel G. Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer? G. J. O. Issue 36, 2021
A48. Erdogan AP, Ekinci F, Karabas A, Balcık OY, Barutca S, Dirican A.Could the Inflammatory Prognostic Index Predict the Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer? Journal of Gastrointestinal Cancer. Published online 21 April 2021. https://doi.org/10.1007/s12029-021-00642-w
A49. Ekinci F, Dirican A, Altınısık M, Ovalı GY, Erdogan AP, Goksel G. Retinal Detachment Due to Choroidal Metastasis in a Patient with Lung Cancer. Tepecik Eğit. ve Araşt. Hast. Dergisi 2021;31(2):269-71 doi:10.5222/terh.2021.08769
A50. Almacan B, Gokcen S, Kılınc M, Ekinci F, Dirican A, Ozturk G, Erdogan AP. The effects of enteral and parenteral nutrition on clinical outcomes in cancer inpatients receiving palliative care. D J Med Sci 2020;6(2):49-52
A51. Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S.Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Eur Urol Focus. 2021 Sep;7(5):1061-1066. doi: 10.1016/j.euf.2020.09.010. Epub 2020 Sep 30.PMID: 33008789
A52. Yolcu A, Dirican A, Ozturk G, Cetin B, Aydogdu I. A rare parasitic infection: visceral leishmaniasis case after gastric cancer treatment. memo (2018) 11:345–347 https://doi.org/10.1007/s12254-018-0437-6
A53. Vinorelbine Induced Serpentine Supravenous Hyperpigmentation. Yetut A, Tas S, Ekinci F, Celik C, Erdogan A, Dirican A. J Oncol Sci. 2022;8(1):54-6. DOI: 10.37047/jos.2022-88125
A54- Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S.Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab Int J Clin Oncol 2021 Aug;26(8):1506-1513. doi: 10.1007/s10147-021-01936-6. Epub 2021 May 23.
A55-Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer. Clin Respir J. 2017 Nov;11(6):789-796. doi: 10.1111/crj.12417. Dirican N, Karakaya YA, Gunes S, Daloglu FT, Dirican A
B. Написанные книги или главы в книгах
Переводы глав из международных книг
1-Devita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology; 10-е издание,
2018;
Глава 47 Генетическое тестирование при раке желудка;
Глава 62 Молекулярная биология рака почки
2-Oxford Handbook of Oncology .Jim Cassidy, Donald Bissett , Roy A. J. Spence OBE ,
Miranda Payne, and Gareth Morris-Stiff. 4-е издание, 2015,
Глава: Онкологические заболевания мочеполовой системы
ГЛАВА В НАЦИОНАЛЬНОМ ИЗДАНИИ
1-Türkiye Klinikleri Медицинская онкология: Редкие опухоли 2020, глава «Редкие виды рака почки», 1-е
издание. Анкара: Türkiye Klinikleri; 2020. С. 104-9.
C. Статьи, опубликованные в национальных рецензируемых журналах:
C1-Demir L, Rezanko T, Akyol M, Bayoglu V, Dirican A, Can A, Cokmert S, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Tarhan MO. Malıgnant hemangıoperıcytoma; report of two cases wıth dıfferent behavıour and revıew of lıterature. Türkiye Klinikleri Journal of Medical Research-Case Reports.2013;21(1):18-23
C2-Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V, Akyol M, Ekinci N, Medeni M, Alacacioglu A. Induction or Adjuvant Docetaxel/Cisplatin Chemotherapy in Advanced Non-Metastatic Nasopharyngeal Cancer.Kocatepe Tıp Dergisi. 2014;15(1):92-8
C3-Ekinci F, Erdogan AP, Dirican A, Göksel G. Влияние соотношения нейтрофилов и лимфоцитов на прогноз у наших пациентов с диагнозом метастатического почечно-клеточного рака. Abant Med J 2021;10 (1):136-141
C4- Erdogan AP, Ekinci F, Dirican A, Celik C, Eniseler EB, Almacan B, Goksel G.The Effect of Neutrophil Lymphocyte Ratio on Prognosis of Ovarian Cancer. Türk Jinekolojik Onkoloji Dergisi 2020-1, Страницы 13-16
C5- Kolkıran N, Ekinci F, Erdogan AP, Goktan C, Goksel G, Dirican A. High Grade Neuroendocrine Carcinoma Diagnosed by Superior Vena Cava Syndrome: Case Report. CBU-SBED, 2020, 7(2): 243-246
C6- Erdogan AP, Ekinci F, Ozveren A, Celik C, Ates GA, Akay S, Dirican A. Evaluation of Clinical and Prognostic Features in Hepatocellular Carcinoma: A Single Center Experience.CBU-SBED, 2021, 8(3): 410-413
C7- Skin Toxicity caused by Cranial Radiotherapy in Lapatinib - Capecitabine Treatment: A Case Report. Eniseler EB, Ekinci F, Erdoğan AP, Dirican A, Goksel G. Türk Jinekolojik Onkoloji Dergisi 2020-1, Страницы 21-24
C8- Dirican A, Dirican N, Ölmezoğulu A. Может ли жидкостная биопсия заменить тканевую биопсию при выявлении таргетных драйверных мутаций при распространённом немелкоклеточном раке лёгкого? CBÜ SBED, 2016, 3(2):165-168
Русский